Literature DB >> 21252945

Development of polypoidal lesions in age-related macular degeneration.

A Tsujikawa1, Y Ojima, K Yamashiro, S Ooto, H Tamura, I Nakata, N Yoshimura.   

Abstract

PURPOSE: To investigate the development of polypoidal lesions using indocyanine green angiography (IA) in eyes with typical age-related macular degeneration (AMD).
METHODS: We retrospectively reviewed the medical records of 47 consecutive patients (47 eyes) with typical AMD who had been followed up with IA for at least 2 years.
RESULTS: At the initial visit, although all eyes showed classic and/or occult choroidal neovascularization (CNV) associated with AMD, no eyes showed polypoidal lesions by IA. However, during follow-up, 13 (27.7%) of the 47 eyes did show polypoidal lesions. All polypoidal lesions developed at the edge of persistent CNV or, more often, at the terminus of recently progressed CNV. Of 12 eyes with a final lesion area >8 disc area, 7 (58.3%) showed newly developed polypoidal lesions. In the eyes with these newly developed polypoidal lesions, the mean area of the vascular lesion had extended significantly from 10.50 ± 7.88 mm² to 20.87 ± 10.21 mm² during follow-up (P=0.0018).
CONCLUSION: The current observation suggests that IA of active AMD sometimes reveals polypoidal lesions if there is progression of the CNV in the subretinal pigment epithelium space.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252945      PMCID: PMC3171253          DOI: 10.1038/eye.2010.232

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  41 in total

1.  Treatment of polypoidal choroidal vasculopathy by intravitreal injection of bevacizumab.

Authors:  Akitaka Tsujikawa; Sotaro Ooto; Kenji Yamashiro; Hiroshi Tamura; Atsushi Otani; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes.

Authors:  Akiko Okubo; Noboru Arimura; Noriko Abematsu; Taiji Sakamoto
Journal:  Acta Ophthalmol       Date:  2010-03-12       Impact factor: 3.761

3.  Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.

Authors:  Luiz H Lima; Carl Schubert; Daniela C Ferrara; Joanna E Merriam; Yutaka Imamura; K Bailey Freund; Richard F Spaide; Lawrence A Yannuzzi; Rando Allikmets
Journal:  Ophthalmology       Date:  2010-04-08       Impact factor: 12.079

4.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration.

Authors:  L A Yannuzzi; D W Wong; B S Sforzolini; M Goldbaum; K C Tang; R F Spaide; K B Freund; J S Slakter; D R Guyer; J A Sorenson; Y Fisher; D Maberley; D A Orlock
Journal:  Arch Ophthalmol       Date:  1999-11

5.  Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.

Authors:  Alexandros N Stangos; Jagdeep Singh Gandhi; Jayashree Nair-Sahni; Heinrich Heimann; Constantin J Pournaras; Simon P Harding
Journal:  Am J Ophthalmol       Date:  2010-08-16       Impact factor: 5.258

6.  Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population.

Authors:  Keisuke Mori; Kuniko Horie-Inoue; Peter L Gehlbach; Hiroyasu Takita; Sho Kabasawa; Izumi Kawasaki; Tomoko Ohkubo; Susumu Kurihara; Hiroyuki Iizuka; Yumi Miyashita; Shigehiro Katayama; Takuya Awata; Shin Yoneya; Satoshi Inoue
Journal:  Ophthalmology       Date:  2010-02-04       Impact factor: 12.079

7.  Polypoidal choroidal vasculopathy: an angiographic discussion.

Authors:  T H Lim; A Laude; C S H Tan
Journal:  Eye (Lond)       Date:  2010-01-15       Impact factor: 3.775

8.  Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.

Authors:  Minhee Cho; Irene A Barbazetto; K Bailey Freund
Journal:  Am J Ophthalmol       Date:  2009-04-29       Impact factor: 5.258

9.  ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Norimoto Gotoh; Hideo Nakanishi; Hisako Hayashi; Ryo Yamada; Atsushi Otani; Akitaka Tsujikawa; Kenji Yamashiro; Hiroshi Tamura; Masaaki Saito; Kuniharu Saito; Tomohiro Iida; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2009-03-09       Impact factor: 5.258

10.  Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.

Authors:  Gregg T Kokame; Ling Yeung; James C Lai
Journal:  Br J Ophthalmol       Date:  2009-09-01       Impact factor: 4.638

View more
  5 in total

1.  A 5-year multicenter prospective cohort study on the long-term visual prognosis and predictive factors for visual outcome in Japanese patients with age-related macular degeneration: the AMD2000 study.

Authors:  Yumiko Akagi-Kurashige; Akitaka Tsujikawa; Mitsuko Yuzawa; Tatsuro Ishibashi; Hideo Nakanishi; Eiji Nakatani; Satoshi Teramukai; Masanori Fukushima; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2017-12-09       Impact factor: 2.447

2.  Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern.

Authors:  Saeed T Alshahrani; Hanan N Al Shamsi; Eman S Kahtani; Nicola G Ghazi
Journal:  Clin Ophthalmol       Date:  2014-09-01

3.  Pachychoroid neovasculopathy in extramacular choroidal neovascularization.

Authors:  Mrinali Patel Gupta; Irene Rusu; Carly Seidman; Anton Orlin; Donald J D'Amico; Szilard Kiss
Journal:  Clin Ophthalmol       Date:  2016-07-12

Review 4.  Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

Authors:  Kenji Yamashiro; Yoshikatsu Hosoda; Masahiro Miyake; Sotaro Ooto; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

Review 5.  Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy.

Authors:  Kenji Yamashiro; Yasuo Yanagi; Hideki Koizumi; Hidetaka Matsumoto; Chui Ming Gemmy Cheung; Fumi Gomi; Tomohiro Iida; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.